Inspire Medical Systems, Inc. INSP recently announced that the FDA has approved its Inspire V therapy system. This next-generation system includes a cutting-edge neurostimulator and a Bluetooth ...

In a report released yesterday, Larry Biegelsen from Wells Fargo maintained a Hold rating on Inspire Medical Systems (INSP – Research Report), with a price target of $187.00. Larry Biegelsen has ...

Inspire Medical Systems is poised for significant growth in 2025, driven by the full-scale launch of the Inspire V system. Management remains confident in achieving its revenue and profitability ...

BofA upgrades Inspire Medical to Buy, setting a $255 price target. The company aims for $950 million in 2025 revenue, with a focus on new product launches and expansion.